NCT00248937

Brief Summary

We will conduct an empirical test of the two intervention approaches under study. Specifically, we seek to determine the potential differential impact of positive affect induction and self affirmation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at below P25 for not_applicable hypertension

Timeline
Completed

Started Feb 2004

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2004

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2004

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

November 3, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 4, 2005

Completed
Last Updated

April 3, 2008

Status Verified

April 1, 2008

First QC Date

November 3, 2005

Last Update Submit

April 1, 2008

Conditions

Hypertension

Keywords

African-AmericanHypertensionMedication adherenceRisk reduction

Outcome Measures

Primary Outcomes (1)

  • Within patient change on the Positive and Negative Affect Scale

Interventions

Positive affect and self-affect inductionBEHAVIORAL

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must be self-identified as African-Americans.
  • All patients must be aged 18 years and older.
  • All patients must be diagnosed as having hypertension: For this project, hypertension will be defined according to the widely accepted criteria of the 6th Joint National Committee (JNC VI) Guidelines on Prevention, Detection, Evaluation and Treatment of Hypertension, which is a systolic blood pressure \> 140 mm hg or a diastolic blood pressure \> 90 mm hg or if participants are taking any prescribed antihypertensive medication.
  • Patients must be able to provide informed consent in English.

You may not qualify if:

  • Patients who are unable to walk several blocks for any reason.
  • Patients who refused to participate
  • Patients who are unable to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The New York Presbyterian Hospital-Weill Medical Center

New York, New York, 10021, United States

Location

MeSH Terms

Conditions

HypertensionMedication AdherenceRisk Reduction Behavior

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Carla Boutin-Foster, MD, MS

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

  • Gbenga Ogedegbe, MD, MS

    Columbia University

    PRINCIPAL INVESTIGATOR

  • Mary E Charlson, MD

    Weill Medical College of Cornell University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 3, 2005

First Posted

November 4, 2005

Study Start

February 1, 2004

Study Completion

June 1, 2004

Last Updated

April 3, 2008

Record last verified: 2008-04

Locations

US(1)